1. Home
  2. JANX vs GNW Comparison

JANX vs GNW Comparison

Compare JANX & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JANX
  • GNW
  • Stock Information
  • Founded
  • JANX 2017
  • GNW 1871
  • Country
  • JANX United States
  • GNW United States
  • Employees
  • JANX N/A
  • GNW N/A
  • Industry
  • JANX Biotechnology: Pharmaceutical Preparations
  • GNW Life Insurance
  • Sector
  • JANX Health Care
  • GNW Finance
  • Exchange
  • JANX Nasdaq
  • GNW Nasdaq
  • Market Cap
  • JANX 3.0B
  • GNW 3.0B
  • IPO Year
  • JANX 2021
  • GNW 2004
  • Fundamental
  • Price
  • JANX $39.88
  • GNW $6.95
  • Analyst Decision
  • JANX Strong Buy
  • GNW Hold
  • Analyst Count
  • JANX 11
  • GNW 1
  • Target Price
  • JANX $83.09
  • GNW $7.00
  • AVG Volume (30 Days)
  • JANX 971.4K
  • GNW 3.6M
  • Earning Date
  • JANX 03-07-2025
  • GNW 02-18-2025
  • Dividend Yield
  • JANX N/A
  • GNW N/A
  • EPS Growth
  • JANX N/A
  • GNW N/A
  • EPS
  • JANX N/A
  • GNW 0.20
  • Revenue
  • JANX $13,049,000.00
  • GNW $7,426,000,000.00
  • Revenue This Year
  • JANX $39.66
  • GNW N/A
  • Revenue Next Year
  • JANX N/A
  • GNW N/A
  • P/E Ratio
  • JANX N/A
  • GNW $34.94
  • Revenue Growth
  • JANX 54.12
  • GNW N/A
  • 52 Week Low
  • JANX $7.79
  • GNW $5.67
  • 52 Week High
  • JANX $71.71
  • GNW $7.90
  • Technical
  • Relative Strength Index (RSI)
  • JANX 31.06
  • GNW 47.38
  • Support Level
  • JANX $39.95
  • GNW $6.44
  • Resistance Level
  • JANX $47.46
  • GNW $7.10
  • Average True Range (ATR)
  • JANX 3.73
  • GNW 0.13
  • MACD
  • JANX -1.27
  • GNW 0.03
  • Stochastic Oscillator
  • JANX 5.73
  • GNW 73.57

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.

About GNW Genworth Financial Inc

Genworth Financial is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. most of the revenue is generated by the Long-Term Care Insurance segment. The company earns most of its revenue in the United States.

Share on Social Networks: